Aurelio Zerial

986 total citations
33 papers, 763 citations indexed

About

Aurelio Zerial is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Aurelio Zerial has authored 33 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Epidemiology. Recurrent topics in Aurelio Zerial's work include HIV/AIDS drug development and treatment (7 papers), Biochemical and Molecular Research (5 papers) and HIV Research and Treatment (5 papers). Aurelio Zerial is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Biochemical and Molecular Research (5 papers) and HIV Research and Treatment (5 papers). Aurelio Zerial collaborates with scholars based in France, Switzerland and Italy. Aurelio Zerial's co-authors include Nguyen T. Thuong, Claude Hélène, Georges H. Werner, P. Jollès, Fabienne Parker, D. Migliore-Samour, Marc Lemaître, Denise Guétard, Yvette Hénin and Luc Montagnier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Aurelio Zerial

32 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurelio Zerial France 14 454 133 113 93 91 33 763
Benjamin U. Samuel United States 16 549 1.2× 216 1.6× 201 1.8× 103 1.1× 91 1.0× 22 1.3k
Alexis Musacchio Cuba 19 423 0.9× 252 1.9× 98 0.9× 45 0.5× 99 1.1× 73 1.0k
Michael Lennick Denmark 11 545 1.2× 89 0.7× 315 2.8× 72 0.8× 83 0.9× 12 925
Luke A. Pallansch United States 15 352 0.8× 119 0.9× 85 0.8× 62 0.7× 314 3.5× 24 763
Herbert A. Blough United States 17 397 0.9× 334 2.5× 104 0.9× 59 0.6× 103 1.1× 49 809
Wicher J. Weijer Netherlands 15 559 1.2× 130 1.0× 115 1.0× 25 0.3× 27 0.3× 20 901
Christine Pierrot France 17 245 0.5× 132 1.0× 165 1.5× 153 1.6× 82 0.9× 53 916
Patricia A. Pilling Australia 10 284 0.6× 304 2.3× 45 0.4× 46 0.5× 119 1.3× 11 698
Saman Habib India 23 676 1.5× 155 1.2× 210 1.9× 34 0.4× 138 1.5× 65 1.2k
Lirong Shi United States 12 262 0.6× 135 1.0× 136 1.2× 55 0.6× 102 1.1× 15 847

Countries citing papers authored by Aurelio Zerial

Since Specialization
Citations

This map shows the geographic impact of Aurelio Zerial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurelio Zerial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurelio Zerial more than expected).

Fields of papers citing papers by Aurelio Zerial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurelio Zerial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurelio Zerial. The network helps show where Aurelio Zerial may publish in the future.

Co-authorship network of co-authors of Aurelio Zerial

This figure shows the co-authorship network connecting the top 25 collaborators of Aurelio Zerial. A scholar is included among the top collaborators of Aurelio Zerial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurelio Zerial. Aurelio Zerial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nohynek, Gerhard J., et al.. (1996). Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Cancer Chemotherapy and Pharmacology. 39(3). 259–266. 14 indexed citations
2.
Rabault, B., et al.. (1992). Mode of action of the antitumor compound girodazole (RP 49532A, NSC 627434). Biochemical Pharmacology. 43(8). 1717–1723. 23 indexed citations
3.
Faraj, Achraf Al, Michel Maillard, Marc Lemaître, et al.. (1992). Synthesis and evaluation of new 2′,3′-dideoxynucleoside analogs as potential anti-AIDS and anti-herpes drugs. European Journal of Medicinal Chemistry. 27(2). 141–148. 6 indexed citations
4.
Monier, R., et al.. (1992). Metastatic phenotype of murine tumor cells expressing different cooperating oncogenes. International Journal of Cancer. 51(5). 798–804. 1 indexed citations
5.
Lavelle, François, et al.. (1991). Antitumor activity and mechanism of action of the marine compound girodazole. Investigational New Drugs. 9(3). 233–244. 23 indexed citations
6.
Lemaître, Marc, Denise Guétard, Yvette Hénin, Luc Montagnier, & Aurelio Zerial. (1990). Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Research in Virology. 141(1). 5–16. 87 indexed citations
7.
Birg, Françoise, Danièle Praseuth, Aurelio Zerial, et al.. (1990). Inhibition of Simian Virus 40 DNA replication in CV-1 cells by an oligodeoxynucleotide covalently linked to an intercalating agent. Nucleic Acids Research. 18(10). 2901–2908. 95 indexed citations
8.
Zerial, Aurelio, et al.. (1990). Synthesis of new (.+-.)-3,5-dihydroxypentyl nucleoside analogs from 1-amino-5-(benzyloxy)pentan-3-ol and their antiviral evaluation. Journal of Medicinal Chemistry. 33(9). 2476–2480. 12 indexed citations
9.
Commerçon, Alain, et al.. (1989). Selective inhibition of tyrosine protein kinase by a synthetic multisubstrate analog. Biochemical and Biophysical Research Communications. 165(3). 1324–1330. 6 indexed citations
10.
Zerial, Aurelio, Nguyen T. Thuong, & Claude Hélène. (1987). Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent. Nucleic Acids Research. 15(23). 9909–9919. 99 indexed citations
11.
Zerial, Aurelio, Barbara Skerlavaj, Renato Gennaro, & Domenico Romeo. (1987). Inactivation of herpes simplex virus by protein components of bovine neutrophil granules. Antiviral Research. 7(6). 341–352. 16 indexed citations
12.
Lavelle, François, et al.. (1987). Synthesis and experimental anti-tumor activities of 6-alkyl (or aryl) thio 5-deazapteridines. European Journal of Medicinal Chemistry. 22(2). 135–137. 6 indexed citations
13.
Zerial, Aurelio, et al.. (1985). Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers. Antimicrobial Agents and Chemotherapy. 27(5). 846–850. 22 indexed citations
14.
Zerial, Aurelio, Ara G. Hovanessian, Simon Stefanos, et al.. (1982). Synergistic activities of type I (α, β) and type II (γ) murine interferons. Antiviral Research. 2(4). 227–239. 40 indexed citations
15.
Migliore-Samour, D., et al.. (1980). A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar. Life Sciences. 26(11). 883–888. 37 indexed citations
16.
Zerial, Aurelio, et al.. (1980). Comparative effects of an inflammatory reaction on the resistance of mice to bacterial and viral infections.. PubMed. 131C(2). 177–84. 3 indexed citations
17.
18.
Dunham, Philip B., et al.. (1977). Membrane fusion: studies with a calcium-sensitive dye, arsenazo III, in liposomes.. Proceedings of the National Academy of Sciences. 74(4). 1580–1584. 20 indexed citations
19.
Zerial, Aurelio, et al.. (1974). The Electrophoretic Properties of Some Human Blood Cells. Vox Sanguinis. 26(1). 14–25. 1 indexed citations
20.
Zerial, Aurelio & D. J. Wilkins. (1972). Electrophoretic behaviour of some human blood cells. Cellular and Molecular Life Sciences. 28(12). 1435–1436. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026